-
Views
-
Cite
Cite
Valérie Allamand, Yoshihide Sunada, Mustafa A. M. Salih, Volker Straub, O. Ozo, M. H. S. Al-Turaiki, Maksood Akbar, Timo Kolo, Holly Colognato, Xu Zhang, Lydia M. Sorokin, Peter D. Yurchenco, Karl Tryggvason, Kevin P. Campbell, Mild Congenital Muscular Dystrophy in Two Patients with an Internally Deleted Laminin α2-Chain, Human Molecular Genetics, Volume 6, Issue 5, 1 May 1997, Pages 747–752, https://doi.org/10.1093/hmg/6.5.747
- Share Icon Share
Abstract
Congenital muscular dystrophy (CMD) is a group of clinically and genetically heterogeneous disorders inherited in an autosomal recessive mode. The α2-chain of laminin-2 (previously called merosin) has been shown by immunohistochemical and genetic analyses to be implicated in the pathogenesis of the “classic” form of CMD. In the “merosin-deficient” subgroup, which represents about half of the cases, more definite evidence of the involvement of the laminin α2-chain has recently been reported with the identification of mutations in the gene encoding the α2-chain of laminin 2 (LAMA2) in CMD patients. Here we report on two siblings from a consanguineous family expressing an internally deleted laminin α2-chain as a result of a splice site mutation in the LAMA2 gene which causes the splicing of exon 25. The predicted protein lacks 63 amino acids in domain IVa which forms a globular structure on the short arm of the α2-chain. Interestingly, these patients appear mildly affected compared to others who completely lack this protein. This situation presents a striking analogy with Becker muscular dystrophy, where in-frame deletions in the dystrophin gene result in the expression of a semi-functional protein and lead to a mild phenotype.